March 12, 2025

Clinical Trials

Adiso Therapeutics Announces Data Publication of Two Phase 1 Studies of First-in-Class Neutrophil Modulator ADS051 in the American Journal of Gastroenterology | Newswise

Adiso Therapeutics Announces Data Publication of Two Phase 1 Studies of First-in-Class Neutrophil Modulator ADS051 in the American Journal of Gastroenterology | Newswise

David Bale010 mins

Newswise — CONCORD, Mass., March 6, 2025 /PRNewswire/ — Adiso Therapeutics, Inc. announced the publication of the results of two Phase 1 studies, which showed that healthy subjects and ulcerative colitis (UC) patients given oral doses of ADS051, a novel modulator of neutrophils being developed for Inflammatory Bowel Disease (IBD), could be safely administered and well-tolerated in…

Read More
The Focused Ultrasound Foundation Designates Columbia University as a Center of Excellence | Newswise

The Focused Ultrasound Foundation Designates Columbia University as a Center of Excellence | Newswise

David Bale07 mins

Newswise — Charlottesville, VA—The Focused Ultrasound Foundation has designated Columbia University as a Focused Ultrasound Center of Excellence, recognizing its leadership in research and innovation. Columbia University is the 7th Center of Excellence in the US and the 14th worldwide. Established in 2009, the Foundation’s Center of Excellence Program recognizes luminary sites for their merit…

Read More
Paxlovid’s Impact on Hospitalization and Death in COVID-Vaccinated Older Adults Far Weaker Than Previously Thought | Newswise

Paxlovid’s Impact on Hospitalization and Death in COVID-Vaccinated Older Adults Far Weaker Than Previously Thought | Newswise

David Bale07 mins

Newswise — Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.  The study questions the assumption that Paxlovid’s effectiveness in reducing COVID-19 hospitalizations and deaths in unvaccinated adults also applies to vaccinated adults. Pfizer’s 2022 clinical trial found reduced COVID-19 hospitalization in unvaccinated middle-aged adults; while…

Read More
The Focused Ultrasound Foundation Designates Columbia University as a Center of Excellence | Newswise

Innovative Research to Advance Oligonucleotide Therapeutics now published in the Journal of Nucleic Acid Therapeutics | Newswise

David Bale07 mins

Newswise — LIMERICK, Pa., Feb. 25, 2025 /PRNewswire/ — Rockland Immunochemicals, Inc. is pleased to announce that Dr. David P. Chimento, Vice President of Research and Development, Amy L. Anderson, Technical Applications Specialist, and Dr. Carl Ascoli, Chief Science Officer, working with Inês Fial, Research Assistant at the Nucleic Acid Therapeutics Accelerator (NATA, Oxford, United Kingdom), have…

Read More
Study on New Telerehabilitation Stroke Therapy Model Led by UTHealth Houston for Underserved Community in the Texas Rio Grande Valley | Newswise

Study on New Telerehabilitation Stroke Therapy Model Led by UTHealth Houston for Underserved Community in the Texas Rio Grande Valley | Newswise

David Bale04 mins

Newswise — A new at-home telerehabilitation care service for stroke patients will be offered to residents of Cameron County in the Texas Rio Grande Valley as part of a randomized clinical trial led by researchers from across UTHealth Houston. Investigators from UTHealth Houston School of Public Health in Brownsville, UTHealth Houston Institute for Stroke and Cerebrovascular Diseases, and McWilliams…

Read More
Short-Course Radiation Therapy Effective for Endometrial Cancer Patients | Newswise

Short-Course Radiation Therapy Effective for Endometrial Cancer Patients | Newswise

David Bale07 mins

Newswise — In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had similar effectiveness to more frequent, lower dose sessions. Gita Suneja, MD, MS, physician-scientist at Huntsman Cancer Institute and professor of radiation oncology at the U, is the first…

Read More
UM School of Medicine Surgeon-Scientists to Co-Lead Large International Clinical Trial to Determine Most Effective Treatment for Common Hip Fracture in Older Adults | Newswise

UM School of Medicine Surgeon-Scientists to Co-Lead Large International Clinical Trial to Determine Most Effective Treatment for Common Hip Fracture in Older Adults | Newswise

David Bale015 mins

Newswise — Hip fractures in older adults can lead to serious complications, disability and even death. Traditionally, orthopaedic surgeons have repaired a common fracture of the upper part of the thigh bone, or femur, near the hip using screws and plates to piece together slightly separated pieces of bone. But many surgeons now treat these…

Read More
The Focused Ultrasound Foundation Designates Columbia University as a Center of Excellence | Newswise

Pacientes com doença de pele respondem a tratamento direcionado | Newswise

David Bale07 mins

Newswise — PHOENIX — Pesquisadores da Mayo Clinic identificaram uma terapia direcionada que pode trazer alívio para as pessoas que vivem com líquen plano, uma condição inflamatória crônica da pele, cabelo, unhas, boca e genitais. Eles descreveram suas descobertas em um estudo publicado no Journal of Clinical Investigation, relatando seu primeiro ensaio clínico em humanos, fase 2….

Read More